Hoeseltpharma SRL
3.1 FTEHoeseltpharma reported total assets of €1.76m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026), with 3.1 full-time equivalents.
The score of Hoeseltpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +38 % Total assets -1 % Headcount (avg FTE) -18 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hoeseltpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Hoeseltpharma's financial analysis
- Solvency71.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hoeseltpharma
Hoeseltpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0826.754.259
- VAT number
- BE0826754259
- Peppol
- Registered · 0208:0826754259 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jun 2010
- Registered office
- 3730 Bilzen-Hoeselt
- Size
- Micro · 3.1 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Hoeseltpharma (SRL) has been based in Bilzen-Hoeselt since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 115,196 € and equity of €1.26m; its revenue is not published. With 3.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 71.8%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hoeseltpharma
Companies in the same business, of comparable size and area, outside its group.
- Astella Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet 603,476 €
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
- Apotheek Ruelens Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 875,961 €
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- Degrofarm Retail sale of pharmaceutical products Deinze · balance sheet €1.47m
- Bayart Hensies Retail sale of pharmaceutical products Dour · balance sheet €1.14m
- Thomas Paesen Retail sale of pharmaceutical products Oudsbergen · balance sheet €1.46m
- Wille Sandrina Retail sale of pharmaceutical products Grimbergen · balance sheet €4.26m
Frequently asked questions about Hoeseltpharma
What is the revenue of Hoeseltpharma?
Hoeseltpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hoeseltpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0826754259 for Hoeseltpharma, if the company is VAT-registered. Its company number (CBE) is 0826.754.259.
Where is the registered office of Hoeseltpharma?
According to the CBE register, the registered office of Hoeseltpharma is in 3730 Bilzen-Hoeselt.
What is the equity of Hoeseltpharma?
At the close of the 2025 financial year, the equity of Hoeseltpharma amounts to 1,260,544 €, a solvency of 71.8% of total assets.
How many people work at Hoeseltpharma?
3.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Hoeseltpharma?
The register lists 1 active mandates at Hoeseltpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hoeseltpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →